Abstract
Medulloblastoma is a childhood brain tumor traditionally classified into four molecular subgroups. Recent evidence suggests that Groups 3 and 4 represent a biological continuum rather than distinct entities, a paradigm shift with significant implications for understanding disease biology and treatment strategies. Nevertheless, assessing this hypothesis is challenging mainly due to data scarcity. In this study, we utilize transcriptomics data to provide evidence supporting the existence of an intermediate subgroup between Groups 3 and 4 with distinct molecular features. Leveraging synthetic data generation with a Variational Autoencoder, we address data scarcity limitations effectively. Our findings are corroborated by prior studies employing different methodologies and datasets, further reinforcing the robustness of our results. Additionally, we apply explainability techniques to the VAE, uncovering key relationships between gene expression and disease subgroups. This study demonstrates the potential of synthetic data generation to refine rare disease subtyping and advance our understanding of the underlying biological mechanisms.

This publication has 81 references indexed in Scilit: